What is INSIGHTEC?
Established in 1999 and headquartered in Haifa, Israel, INSIGHTEC is at the forefront of developing and commercializing groundbreaking medical technologies. The company's core innovation lies in its incisionless magnetic resonance-guided focused ultrasound (MRgFUS) technology, which offers non-invasive treatment options for a range of medical conditions, including essential tremor, Parkinson's disease, and uterine fibroids. By integrating MRI for precise targeting and real-time monitoring with focused ultrasound energy, INSIGHTEC provides a safer and more effective alternative to traditional surgical interventions. This approach aims to significantly improve patient outcomes and reduce recovery times, positioning INSIGHTEC as a key player in the rapidly evolving field of therapeutic ultrasound and image-guided therapy.
How much funding has INSIGHTEC raised?
INSIGHTEC has raised a total of $784.9M across 8 funding rounds:
Series B
$15M
Series C
$30.9M
Series D
$59M
Series E
$150M
Other Financing Round
$150M
Debt
$200M
Private Equity
$150M
Series B (2009): $15M led by Elbit Imaging Ltd.
Series C (2012): $30.9M supported by GE Healthcare
Series D (2014): $59M featuring GE Healthcare, York Capital, Boston MedTech Advisors, and Elbit Imaging Ltd.
Series E (2017): $150M backed by York Capital, Focus Holdings, Elbit Imaging Ltd., KDT, and GE Healthcare
Other Financing Round (2020): $150M with participation from Koch
Debt (2022): $200M led by Perceptive Advisors and The Community Fund Vc
Private Equity (2024): $150M supported by Fidelity Investments, Baillie Gifford, Ally Bridge Group, and Nexus NeuroTech Ventures
Key Investors in INSIGHTEC
Fidelity Investments
Fidelity Investments is an international provider of financial services and investment resources that help individuals and institutions meet their financial objectives. Their participation suggests a strong belief in INSIGHTEC's long-term financial viability and market potential.
Ally Bridge Group
Ally Bridge Group is a global healthcare investment management firm specializing in high-impact life science innovation. Their involvement indicates a strategic focus on advancing INSIGHTEC's cutting-edge medical technologies within the healthcare sector.
Nexus NeuroTech Ventures
Nexus NeuroTech Ventures is dedicated to advancing breakthrough technologies for neurological and psychiatric disorders. Their investment in INSIGHTEC highlights the company's significant contributions to treating conditions like essential tremor and Parkinson's disease.
What's next for INSIGHTEC?
With the recent influx of major strategic investment, INSIGHTEC is poised for accelerated growth and further innovation. The company is expected to leverage this capital to expand its global commercial reach, enhance its research and development pipeline for new indications and improved technologies, and potentially scale its manufacturing capabilities. The enterprise-level funding suggests a focus on market penetration and solidifying its position as a leader in incisionless treatments. Future developments may include broader adoption of its MRgFUS platforms in clinical practice worldwide, further clinical trials to validate new applications, and strategic partnerships to broaden access to its transformative therapies. This strategic financing is a testament to the company's strong market potential and its commitment to advancing patient care through non-invasive medical solutions.
See full INSIGHTEC company page
